Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction.
Daya
Salim
S
Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada. dayas@mcmaster.ca
D002986:Clinical Trials as Topic / Q000379:methods*; D005260:Female; D005300:Fertility Agents, Female / Q000627:therapeutic use*; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use*; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D008596:Menotropins / Q000627:therapeutic use*; D008846:Micromanipulation; D011247:Pregnancy; D011994:Recombinant Proteins / Q000627:therapeutic use; D027724:Reproductive Techniques, Assisted; D016896:Treatment Outcome
D005300:Fertility Agents, Female; D006728:Hormones; D011994:Recombinant Proteins; D008596:Menotropins; D005640:Follicle Stimulating Hormone